However, like FSH and LH, stimulation of human lung cancer cells with prolactin led to downregulation of HO-1 expression and increased the ability of the lung cancer cells to infiltrate other sites in the body (Figure 2B) [164] (Table 3). The gene discussed is PRL; the disease is lung carcinoma.